> Data Asset Self-Reporting in Pharma
Our report, published in Drug Discovery Today, introduces a powerful implementation concept for digital transformation in biopharma.
This paper was co-written by BYU, ZONTAL, Agilent, and Bristol Myers Squibb with input from multiple other large Pharma companies. It explores the need for contextualizing data to create self-reporting data assets. Further, it compares different technologies that are available for reaching the goal of FAIR data in the laboratory. Get free access to the full article below!
Complete the form below to read the paper.
